These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 33930596)

  • 1. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease.
    Xu Y; Zhu Y; Hu S; Pan X; Bawa FC; Wang HH; Wang DQ; Yin L; Zhang Y
    Mol Metab; 2021 Sep; 51():101244. PubMed ID: 33930596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
    Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
    Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
    Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
    Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes.
    Chen L; Wu N; Kennedy L; Francis H; Ceci L; Zhou T; Samala N; Kyritsi K; Wu C; Sybenga A; Ekser B; Dar W; Atkins C; Meadows V; Glaser S; Alpini G
    Hepatology; 2021 Oct; 74(4):1845-1863. PubMed ID: 33928675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
    Liu J; Tang T; Wang GD; Liu B
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).
    Xu Y; Zhu Y; Hu S; Xu Y; Stroup D; Pan X; Bawa FC; Chen S; Gopoju R; Yin L; Zhang Y
    Hepatology; 2021 Jun; 73(6):2251-2265. PubMed ID: 33098092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
    Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise-Induced ADAR2 Protects against Nonalcoholic Fatty Liver Disease through miR-34a.
    Wang Z; Zhu Y; Xia L; Li J; Song M; Yang C
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease.
    Fernández-Tussy P; Fernández-Ramos D; Lopitz-Otsoa F; Simón J; Barbier-Torres L; Gomez-Santos B; Nuñez-Garcia M; Azkargorta M; Gutiérrez-de Juan V; Serrano-Macia M; Rodríguez-Agudo R; Iruzubieta P; Anguita J; Castro RE; Champagne D; Rincón M; Elortza F; Arslanow A; Krawczyk M; Lammert F; Kirchmeyer M; Behrmann I; Crespo J; Lu SC; Mato JM; Varela-Rey M; Aspichueta P; Delgado TC; Martínez-Chantar ML
    Mol Metab; 2019 Nov; 29():40-54. PubMed ID: 31668391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes.
    He Y; Hwang S; Cai Y; Kim SJ; Xu M; Yang D; Guillot A; Feng D; Seo W; Hou X; Gao B
    Hepatology; 2019 Oct; 70(4):1150-1167. PubMed ID: 30964207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice.
    Lee SM; Muratalla J; Karimi S; Diaz-Ruiz A; Frutos MD; Guzman G; Ramos-Molina B; Cordoba-Chacon J
    Cell Mol Life Sci; 2023 Jan; 80(2):39. PubMed ID: 36629912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1.
    Zhang M; Tang Y; Tang E; Lu W
    Biochem Biophys Res Commun; 2020 Apr; 524(3):716-722. PubMed ID: 32035613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis.
    Simão AL; Afonso MB; Rodrigues PM; Gama-Carvalho M; Machado MV; Cortez-Pinto H; Rodrigues CMP; Castro RE
    J Mol Med (Berl); 2019 Aug; 97(8):1113-1126. PubMed ID: 31139863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
    J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-218-5p promotes hepatic lipogenesis through targeting Elovl5 in non-alcoholic fatty liver disease.
    Wu G; Zhang Y; Liang B; Yin L; Gao M; Zhang H; Xu Y; Han X; Qi Y; Liu F; Xu L
    Biochem Pharmacol; 2024 Aug; 226():116411. PubMed ID: 38972428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte-specific expression of human carboxylesterase 2 attenuates nonalcoholic steatohepatitis in mice.
    Xu Y; Pan X; Hu S; Zhu Y; Cassim Bawa F; Li Y; Yin L; Zhang Y
    Am J Physiol Gastrointest Liver Physiol; 2021 Jan; 320(2):G166-G174. PubMed ID: 33325808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.
    Ding J; Li M; Wan X; Jin X; Chen S; Yu C; Li Y
    Sci Rep; 2015 Sep; 5():13729. PubMed ID: 26330104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-Cell-Specific IL-6 Signaling Promotes MicroRNA-223-Enriched Exosome Production to Attenuate NAFLD-Associated Fibrosis.
    Hou X; Yin S; Ren R; Liu S; Yong L; Liu Y; Li Y; Zheng MH; Kunos G; Gao B; Wang H
    Hepatology; 2021 Jul; 74(1):116-132. PubMed ID: 33236445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
    J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression.
    Hanin G; Yayon N; Tzur Y; Haviv R; Bennett ER; Udi S; Krishnamoorthy YR; Kotsiliti E; Zangen R; Efron B; Tam J; Pappo O; Shteyer E; Pikarsky E; Heikenwalder M; Greenberg DS; Soreq H
    Gut; 2018 Jun; 67(6):1124-1134. PubMed ID: 28381526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.